MDY Mdy Healthcare

RNS Number:7637W
Medisys PLC
22 March 2004


Embargoed until 0700                                           22 March 2004 


                                  Medisys PLC

                          ("Medisys" or "the Company")

             Market Launch of Futura Safety Syringe



Medisys announces that it has successfully launched the Futura Safety Syringe in
the US market through its own sales force.



The first major purchase order for the Futura Safety Syringe has been received
from a leading medical products distributor in the US.  Production batches
required to fulfil this order have now been manufactured and shipped to the
customer.  Further sales opportunities for the product are being actively
pursued withthis and other distributors, in addition to which the sales force
is working with key GPO's (group purchasing organisations) to generate pull
through sales.



This initial targeted launch through the Company's own 40 person sales and
marketing team is designed to establish the product in the market place.  The
Group is also continuing to explore alternative major distributor partnership
opportunities for the product, which would help to ensure maximum market
penetration.



In addition, the Company announces that it has also re-launched the Futura
Safety Scalpel, again through its own sales force.  As previously announced,
sales of the Futura Safety Scalpel had been suspended to allow re-design of the
packaging to reflect the change to a direct marketing strategy.  Following
receipt of new packaging materials, the Group re-commenced sales and the first
substantial orders have now been received.  Shipment of product against these
orders has commenced.



Dave Conn, Chief Executive, said: "I am delighted that we have finally launched
the Futura Safety Syringe in the US and it is exciting to have already received
our first substantial order.  Further sales opportunities are currently being
progressed and we are confident of meeting our objective of building a market
presence for the product in this initial launch phase.  The re-launch of the
Futura scalpel, which had previously established a profitable and fast growing
niche in the medical safety products market, is also an important step forward.
We believe that the products have broad market appeal, offering cost effective
solutions to prevent needlestick and sharps injuries amongst healthcare workers.
"



                                    - Ends -



Enquiries:



Medisys PLC                                             020 7563 5200
David Conn, Chief Executive Officer
Michael Barry, Chief Financial Officer


Weber Shandwick Square Mile                             020 7067 0700
Kevin Smith/Susanne Walker








                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

PRLQLLBLZXBEBBX

MDY Healthcare (LSE:MDY)
Historical Stock Chart
Von Jun 2024 bis Jul 2024

MDY Healthcare (LSE:MDY)
Historical Stock Chart
Von Jul 2023 bis Jul 2024